ATE454146T1 - Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung - Google Patents

Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung

Info

Publication number
ATE454146T1
ATE454146T1 AT07808509T AT07808509T ATE454146T1 AT E454146 T1 ATE454146 T1 AT E454146T1 AT 07808509 T AT07808509 T AT 07808509T AT 07808509 T AT07808509 T AT 07808509T AT E454146 T1 ATE454146 T1 AT E454146T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
treatment
production
skin diseases
photosensitizer
Prior art date
Application number
AT07808509T
Other languages
English (en)
Inventor
Geertruida Smijs
Johannes Schuitmaker
Original Assignee
Stichting Tech Wetenschapp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Tech Wetenschapp filed Critical Stichting Tech Wetenschapp
Application granted granted Critical
Publication of ATE454146T1 publication Critical patent/ATE454146T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07808509T 2006-08-29 2007-08-29 Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung ATE454146T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1032375 2006-08-29
PCT/NL2007/000211 WO2008026915A2 (en) 2006-08-29 2007-08-29 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE454146T1 true ATE454146T1 (de) 2010-01-15

Family

ID=38969986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07808509T ATE454146T1 (de) 2006-08-29 2007-08-29 Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (1) US20090264492A1 (de)
EP (1) EP2056820B1 (de)
JP (1) JP2010502595A (de)
AT (1) ATE454146T1 (de)
AU (1) AU2007289419A1 (de)
DE (1) DE602007004230D1 (de)
ES (1) ES2340818T3 (de)
WO (1) WO2008026915A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112717131B (zh) * 2021-01-18 2023-05-02 袁小英 金丝桃素在制备治疗真菌性皮肤病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
JP2006056807A (ja) * 2004-08-18 2006-03-02 Konica Minolta Medical & Graphic Inc 光線力学療法製剤

Also Published As

Publication number Publication date
WO2008026915A2 (en) 2008-03-06
JP2010502595A (ja) 2010-01-28
EP2056820A2 (de) 2009-05-13
US20090264492A1 (en) 2009-10-22
WO2008026915A3 (en) 2008-08-07
DE602007004230D1 (de) 2010-02-25
EP2056820B1 (de) 2010-01-06
ES2340818T3 (es) 2010-06-09
AU2007289419A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
DE602007009995D1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA200970296A1 (ru) Содержащие диариловый эфир соединения мочевины
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
BRPI0508854A (pt) sais farmacêuticos de ácido-3-o-(3',3'-dimetilsuccinil) betulìnico
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
MXPA05007462A (es) Derivados de pirrolopiridazina.
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
MX366496B (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
EA201071307A1 (ru) Карбамоильные производные бициклических карбониламинопиразолов в качестве пролекарств
BRPI0621347B8 (pt) composição farmacêutica para aumentar a produção de eritrócitos e para o tratamento de anemia
GB2446341A (en) Method and system for transdermal drug delivery
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
ATE454146T1 (de) Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties